Are you Dr. Chang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1501 San Pedro Dr Se
Medicine Service, Box 111
Albuquerque, NM 87108Phone+1 505-265-1711Fax+1 505-256-2803
Summary
- Dr. Christopher Chang, MD is a gastroenterologist in Albuquerque, New Mexico. He is currently licensed to practice medicine in New Mexico, New Jersey, and Delaware. He is affiliated with Raymond G. Murphy Department of Veterans Affairs Medical Center and University of New Mexico Hospitals.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1997 - 2001
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1995 - 1997
- University of California San Francisco School of MedicineClass of 1995
Certifications & Licensure
- NM State Medical License 2015 - 2025
- CA State Medical License 1997 - 2020
- DE State Medical License 2010 - 2015
- NJ State Medical License 2011 - 2015
- PA State Medical License 2010 - 2014
- OR State Medical License 1997 - 2013
Publications & Presentations
PubMed
- 6 citationsReal-World Treatment Strategies to Improve Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.Darren M Brenner, Lucinda A Harris, Christopher H Chang, Scott A Waldman, David M Poppers
The American Journal of Gastroenterology. 2022-04-01 - 9 citationsBurden of Constipation: Looking Beyond Bowel Movements.Lucinda A Harris, Christopher H Chang
The American Journal of Gastroenterology. 2022-04-01 - 557 citationsConnecting copper and cancer: from transition metal signalling to metalloplasia.Eva J Ge, Ashley I. Bush, Angela Casini, Paul A. Cobine, Justin R. Cross
Nature Reviews. Cancer. 2021-11-11
Press Mentions
- Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome in Human SubjectsMay 13th, 2020
Grant Support
- DFT Investigations Of Mn(Ii/Iii) Oxalate Oxidase ModelsNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2003